SCHEMBL742470

SCHEMBL742470

CC(C)(NC(=O)c1cc2c(NC(=O)c3ccc(N4CCOCC4)nc3)n[nH]c2s1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 7/20 0.52
ABL1 P00519 2/20 0.51
BCR P11274 2/20 0.51
IMPDH2 P12268 1/20 0.44
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
STAT3 P40763 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP2C19 P33261 1/20 0.41
HDAC10 Q969S8 1/20 0.41
KCNQ3 O43525 1/20 0.40
KCNQ2 O43526 1/20 0.40
KIT P10721 2/20 0.40
BRAF P15056 1/20 0.40
FLT3 P36888 1/20 0.40
IKBKE Q14164 1/20 0.40
TBK1 Q9UHD2 1/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
RPS6KB1 P23443 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL741251 0.90 AURKA (0.64) AURKAABL1BCRMAPTKIT
SCHEMBL4631760 0.86 HDAC10 (0.47) AURKAMAPTSMN1; SMN2STAT3CYP1A2
SCHEMBL742820 0.86 AURKA (0.56) AURKAABL1BCRKITBRAF
SCHEMBL743118 0.84 AURKA (0.49) AURKAABL1BCRMAPTSMN1; SMN2
SCHEMBL742258 0.84 ABL1 (0.65) AURKAABL1BCRMAPTSMN1; SMN2
SCHEMBL740120 0.83 AURKA (0.55) AURKAABL1BCRMAPTKIT
SCHEMBL740826 0.83 AURKA (0.55) AURKAABL1BCRMAPTKIT
SCHEMBL740985 0.82 AURKA (0.77) AURKAABL1BCRKITFLT3
SCHEMBL741174 0.81 AURKA (0.54) AURKAABL1BCRMAPTKIT
SCHEMBL740681 0.81 AURKA (0.54) AURKAABL1BCRMAPTKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed